Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials

por Kishi T, Matsunaga S, Iwata N
Publicado 2018

Memantine for the treatment of frontotemporal dementia: a meta-analysis

por Kishi T, Matsunaga S, Iwata N
Publicado 2015

The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis

por Kishi T, Matsunaga S, Iwata N
Publicado 2017

Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites

por Yoshimura R, Kishi T, Iwata N
Publicado 2019

Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials

por Oya K, Kishi T, Iwata N
Publicado 2015

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine

por Kishi T, Matsunaga S, Matsuda Y, Iwata N
Publicado 2014

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials

por Kishi T, Matsuda Y, Matsunaga S, Iwata N
Publicado 2015

Early prediction of blonanserin response in Japanese patients with schizophrenia

por Kishi T, Matsuda Y, Fujita K, Iwata N
Publicado 2014

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia

por Zhao Y, Kishi T, Iwata N, Ikeda M
Publicado 2013

Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials

por Okuyama Y, Oya K, Matsunaga S, Kishi T, Iwata N
Publicado 2016

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population

por Kishi T, Ikuta T, Matsunaga S, Matsuda Y, Oya K, Iwata N
Publicado 2017

Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials

por Kishi T, Nomura I, Sakuma K, Kitajima T, Mishima K, Iwata N
Publicado 2019

Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder

por Nagao K, Kishi T, Moriwaki M, Fujita K, Hirano S, Yamanouchi Y, Funahashi T, Iwata N
Publicado 2013

A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders

por Kishi T, Matsuda Y, Matsunaga S, Mukai T, Moriwaki M, Tabuse H, Fujita K, Iwata N
Publicado 2016

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study

por Okamoto N, Watanabe K, Ngyuyen LH, Ikenouchi A, Kishi T, Iwata N, Kakeda S, Korogi Y, Yoshimura R
Publicado 2020

Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symp...

por Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Ueda I, Igata N, Kishi T, Iwata N, Abe O, Yoshimura R, Korogi Y
Publicado 2019

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

por Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N
Publicado 2018

Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and...

por Igeta H, Watanabe Y, Morikawa R, Ikeda M, Otsuka I, Hoya S, Koizumi M, Egawa J, Hishimoto A, Iwata N, Someya T
Publicado 2019

A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder

por Katsuki A, Kakeda S, Watanabe K, Igata R, Otsuka Y, Kishi T, Nguyen L, Ueda I, Iwata N, Korogi Y, Yoshimura R
Publicado 2019

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial

por Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N
Publicado 2017